B. Riley Financial Shares Plunge 8.6% as SEC Scrutiny and Buyout Bid Spark Market Turmoil

Shares of B. Riley Financial (NASDAQ: RILY) faced a sharp decline of 8.6% in premarket trading this Monday, marking another low point for the company following a turbulent week. The Los Angeles-based financial institution recently witnessed a rollercoaster ride, as co-founder and co-CEO Bryant Riley attempted to stabilize the situation by proposing a buyout of the firm. Last Friday, despite an overall upward closing of 16% at $5.85, the stock remained below Riley’s unsolicited purchase offer of $7 per share, which places a valuation of $212 million on the investment bank, reflecting a 39% premium compared to its closing price from the previous Thursday.

However, this rebound did little to assuage the fears of investors who had just watched the stock plummet by a staggering 65.5% last week, hitting a ten-year low in the process. The capital upheaval was largely attributed to an ominous warning from B. Riley regarding a potential loss in the second quarter. This forecast heightened anxieties surrounding the firm's ventures, particularly its controversial investment in Vitamin Shoppe-owner Franchise Group (NASDAQ: FRG), which has been under scrutiny as of late.

The situation took a more troubling turn when the firm and its leadership received subpoenas from the U.S. Securities and Exchange Commission back in July. These subpoenas were connected to B. Riley's past dealings with Franchise’s former CEO, Brian Kahn. Adding to the drama, Kahn was reported as a co-conspirator in a securities fraud case involving Prophecy Asset Management, as revealed by various news outlets. Kahn has firmly denied any involvement, asserting that he was unaware of any wrongdoing tied to Prophecy Asset.